Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Virtual CME : JIA Update 2023 - Juvenile Idiopathic Arthritis
The 2023 Virtual Continuing Medical Education (CME) session on Juvenile Idiopathic Arthritis (JIA) provided crucial updates on the latest advancements in the diagnosis and management of this complex pediatric condition. Key topics included the introduction of novel biologic therapies, improved diagnostic criteria, and personalized treatment approaches. Experts highlighted the significance of early and accurate diagnosis, emphasizing the use of advanced imaging techniques and updated clinical guidelines to distinguish JIA subtypes, which is essential for tailoring effective treatment plans.
A major focus of the CME was on the evolving landscape of biologic treatments and their role in achieving disease remission. Presenters discussed the latest data on biologics such as Adalimumab, Tocilizumab, and newer agents targeting specific immune pathways. They also underscored the importance of monitoring for side effects and long-term safety, given the chronic nature of JIA. Additionally, the session addressed the critical role of multidisciplinary care, involving rheumatologists, physical therapists, and pediatricians, to optimize patient outcomes. The virtual format allowed for interactive discussions and case studies, providing participants with practical insights and strategies to enhance their clinical practice in managing JIA.
Therefore, get an overall knowledge of virtual CME : JIA update 2023 - juvenile idiopathi
See More Webinars @ Hidoc Webinars
1.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
2.
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer
3.
A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.
4.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
5.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
1.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
2.
Oncology Communication Simulation: Enhancing Clinical Competence Through Evidence-Based Training
3.
Drug Safety Monitoring of Delayed Hematologic Effects After Prolonged Medication Exposure
4.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
5.
New Research on Craniopharyngioma
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Understanding the Importance of Follow-Up After Cancer Treatment
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge